Keratoconus Journey: Diana

At 14 years old, Diana found herself squinting to see the board at school and while watching television. It wasn’t until a decade later Diana discovered she was living with progressive keratoconus.

Introducing the iLink Copay Savings Program

If your doctor has recommended iLink FDA-approved corneal cross-linking— the first and only FDA-approved therapeutic treatment that stiffens the cornea to slow or halt the progression of keratoconus, then you may now be eligible to receive up to $200 towards your non-reimbursable copay expenses through our new patient support program.